CELLULAR RETENTION, CYTOTOXICITY AND MORPHOLOGICAL TRANSFORMATION BY VANADIUM(IV) AND VANADIUM(V) IN BALB/3T3 CELL-LINES

被引:88
作者
SABBIONI, E
POZZI, G
PINTAR, A
CASELLA, L
GARATTINI, S
机构
[1] UNIV MILAN,CNR CTR,DEPT INORGAN & MET CHEM,I-20133 MILAN,ITALY
[2] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY
关键词
D O I
10.1093/carcin/12.1.47
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytotoxicity, morphological transformation and cellular retention have been studied in BALB/3T3 Cl A 31-1-1 cells for ammonium or sodium vanadate [vanadium(V)] and for vanadyl sulphate [vanadium(IV)]. A morphological transformation focus assay showed transforming activity for vanadium(V) (P < 0.005 at concentrations of 3 X 10(-6) or higher) while vanadium(IV) was not transforming in the cells. Cytotoxicity was higher for vanadium(V) than for vanadium(IV); this was particularly clear at doses from 5 X 10(-6) to 5 X 10(-5)M. The cellular retention of both vanadate and vanadyl compounds at 24, 48 and 72 h incubation was similar. At concentrations lower than 10(-6) M vanadate, the retention was linear with the dose, while at higher exposures the vanadium taken up by the cells levelled off or slightly decreased. Exposure to 10(-6) M and 10(-5) M vanadium(V) for 3 and 24 h as well as to 10(-6) M for 48 and 72 h yielded > 94% vanadium in the cytosol, but exposure to a toxic dose (10(-5) M) for 48 and 72 h yielded 20% vanadium associated with cellular organelles, which suggests that some sites in the cytosol become saturated with vanadium. The corresponding gel-filtration experiments indicate that a redistribution of the element among the cytosol components occurs with time.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 42 条
[1]   CELLULAR UPTAKE AND METABOLIC REDUCTION OF PENTAVALENT TO TRIVALENT ARSENIC AS DETERMINANTS OF CYTOTOXICITY AND MORPHOLOGICAL TRANSFORMATION [J].
BERTOLERO, F ;
POZZI, G ;
SABBIONI, E ;
SAFFIOTTI, U .
CARCINOGENESIS, 1987, 8 (06) :803-808
[2]   CYTOTOXICITY-RELATED ALTERATIONS OF SELECTED CELLULAR FUNCTIONS AFTER INVITRO VANADATE EXPOSURE [J].
BRACKEN, WM ;
SHARMA, RP .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (14) :2465-2470
[3]   VANADATE, EPIDERMAL GROWTH-FACTOR AND THE STIMULATION OF DNA-SYNTHESIS [J].
CARPENTER, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 102 (04) :1115-1121
[4]   INTERACTION OF TRACE LEVELS OF VANADIUM(IV) AND VANADIUM(V) IN BIOLOGICAL-SYSTEMS [J].
CRANS, DC ;
BUNCH, RL ;
THEISEN, LA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1989, 111 (19) :7597-7607
[5]   ELECTRON-PARAMAGNETIC RESONANCE STUDIES AND INSULIN-LIKE EFFECTS OF VANADIUM IN RAT ADIPOCYTES [J].
DEGANI, H ;
GOCHIN, M ;
KARLISH, SJD ;
SHECHTER, Y .
BIOCHEMISTRY, 1981, 20 (20) :5795-5799
[6]   PROOXIDANT PROPERTIES OF VANADATE INVITRO ON CATECHOLAMINES AND ON LIPID-PEROXIDATION BY MOUSE AND RAT-TISSUES [J].
DONALDSON, J ;
LABELLA, F .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1983, 12 (01) :119-126
[7]  
EDEL J, 1988, J TRACE ELEM ELECT H, V2, P23
[8]  
GARATTINI S, 1986, FEST TOXICOLOGY EURO, P19
[9]   PHYSIOLOGICAL AND PHARMACOLOGICAL PROPERTIES OF VANADIUM [J].
JANDHYALA, BS ;
HOM, GJ .
LIFE SCIENCES, 1983, 33 (14) :1325-1340
[10]  
JENSSEN J, 1986, 4TH P SCAND SOC CELL